Jun 24, 2025 · 27m · innovators-investors
Connecting Healthcare: Solving Medical Device Fragmentation with R Group
0:00 / 0:00
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of the Innovators and Investors Podcast, host Christian Marquez interviews R Group CEO Justin Ramsaran about overcoming medical device fragmentation, modernizing healthcare data infrastructure, and scaling a bootstrapped healthtech venture.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
Kristian as informed peer 4.2 Guest teaching 3.6 Guest disagreement 0.2 Kristian pushing back 0.3
speaking balance: gold is Kristian, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 13:55 Guest reframes brand name importance
The guest gently pushes back on the host's premise that a big corporate brand name is the primary key to healthcare sales, emphasizing that deep operational engagement across stakeholder tiers is what actually drives adoption.
Hardest push from Kristian ▶ 3:22 Host questions HL7 effectivenessThe host directly probes industry limitations by pointing out that nonprofit and regulatory efforts like HL7 have largely failed to achieve true interoperability.
Biggest teaching moment ▶ 3:47 Guest explains EMR walled gardens and TEFCAThe guest educates the host on how standardization of data formats failed to resolve proprietary silo battles between Epic and Cerner, introducing new exchange frameworks like TEFCA and QHIN.
Kristian holds their own ▶ 10:56 Host articulates market dynamics and bootstrapping modelThe host demonstrates sharp financial and strategic acumen by dissecting the advantage of taking an existing market rather than making one, validating the guest's transition from services to product.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Kristian as informed peer | Guest teaching | Guest disagreement | Kristian pushing back | Why |
|---|---|---|---|---|---|---|
| The Challenge of Medical Device Fragmentation in Healthcare | 3 | 5 | 1 | 1 | The host asks broad introductory questions to frame healthcare interoperability challenges for the audience. The guest takes over to explain how medical devices were historically built as isolated utilities rather than connected nodes, causing clinical workflow bottlenecks. | |
| Limitations of HL7 and Emerging Data Sharing Frameworks | 5 | 6 | 1 | 1 | The host demonstrates prior industry knowledge by referencing HL7 normalization efforts and regulatory shortcomings. The guest enriches the topic by detailing how EMR silos persist despite HL7, introducing TEFCA and QHIN frameworks. | |
| The Genesis of R Group from Services to Product | 3 | 2 | 0 | 0 | The host inquires into the founding narrative and prior entrepreneurial ventures. The guest shares his history transitioning from dev shop services into product development while bootstrapping with his co-founder. | |
| Lessons on Product-Market Fit and Legacy Systems | 6 | 3 | 0 | 1 | The guest explains finding product-market fit in antiquated legacy workflows. The host steps in with domain analysis on market-making versus market-taking and validates the strategy of using professional services to bootstrap. | |
| Stakeholder Engagement Across Hospital Ecosystems | 4 | 4 | 0 | 0 | The host asks how having an established corporate partner helps navigate conservative healthcare procurement. The guest clarifies that while brand recognition helps, true success requires multi-stakeholder buy-in from basement biomed technicians to C-suite executives. | |
| Prioritizing Customer Success and Long-Term Adoption | 4 | 3 | 0 | 0 | The host explores capital allocation across early-stage operations, prompting the guest to emphasize customer success and adoption stickiness over simple IT support. The conversation remains highly aligned and collaborative. | |
| Responsiveness Metrics and Service Level Commitments | 5 | 2 | 0 | 0 | The guest explains their company SLA philosophy of prioritizing substantive, contextual responses over generic automated support tickets. The host demonstrates operational expertise by sharing how his own firm manages inboxes and response SLAs. | |
| AI Augmentation and Multimodal Clinical Insights | 3 | 5 | 0 | 0 | The host asks about the transformative impact of AI on medtech. The guest articulates a vision of AI as clinical augmentation using structured multimodal data to detect conditions like strokes rather than replacing clinicians. | |
| Embracing Unconventional Paths in Entrepreneurship | 5 | 2 | 0 | 0 | The guest reflects on advising his younger self to pursue unconventional paths. The host enriches the exchange by framing unconventional entrepreneurship through statistical fat-tail distributions. |
Statements from this episode (12)
Ramsaran: Clinicians spend 80% of their day updating medical records
“What's occurred is you've got clinicians being away from the bedside, and there's now inside of the terminal, we'll call it, but the medical records, 80% of the day taking notes and updating information, reducing what's going on at the bedside care standpoint.”
Ramsaran: Proprietary vendor connections keep medical device interoperability fragmented
“Interoperability continues to be fragmented because each solution vendor is coming out with their own proprietary connection. You've got, you know, we'll, we'll call it the big names, but if you've got a patient monitor and a ventilator, you've got to use this…”
Ramsaran: Epic and Cerner maintain data silos to preserve competitive advantage
“And if you are in the Epic platform, you can't talk to the Cerner platform, right? It's how they kind of keep their Competition, but also keep the information within these own silos as well.”
Ramsaran: Data exchange frameworks will force medical device makers into open architectures
“That comes from a downstream of areas too, where it will start to impact medical device manufacturers needing to meet, be more data oriented, and be able to have more open architectures and the ways that they communicate the information.”
Ramsaran: Adding standalone healthcare AI applications increases systemic fragmentation
“Everyone is now creating new data systems, creating new AI applications, AI devices, but inherently, if you're adding these in, you're also creating more fragmentation because We now have to use this AI application that only works with this device or only will…”
Ramsaran: Connecting one medical device modality in hospitals takes eight months of meetings
“Sitting in the hospital conversation. I've got a med device vendor, I've got IT, and then I've got me as a sales engineer at one point. Having to have, you know, eight month long meetings to connect one single modality. And that, you know, dies on the vine, ri…”
Ramsaran: Founders should modernize boring, antiquated legacy systems
“Find a niche solution and something that seems very antiquated or boring as a legacy system and make it better, right? I think that's the big thing we learned in the simplest of ways.”
Ramsaran: Healthtech Sales Must Engage All Hospital Tiers, From IT to C-Suite
“It's not just the clinical person. It's not just a CIO or CFO. It's everyone at the table. We're talking to the guys that are in the basement, the biomed guys who work with the devices, the IT guys that get burnt out because they have to operate and manage the…”
Ramsaran: Turning Data Projects into Data Strategies Shortens Healthcare Sales Cycles
“Our biggest secret, I would say, I think it's the simplest one. That's the easy to be shared is helping those projects go from a data project to a data strategy. That has been the best approach we've taken.”
Ramsaran: Healthcare Tech Cannot Be Deployed and Forgotten in 90 Days
“You deploy a solution, medical device, or even again, a software application for healthcare, and you can't just come in and deploy something in 90 days, support it for 90 days, and then set it and forget it. Healthcare's dynamic. You've got to find a way to be…”
Ramsaran: Healthcare AI Will Detect Onset Strokes and Ischemia Within Years
“I think we're not too far, and, you know, maybe the next coming years of, we've got enough cardiac information that you should be able to detect a patient with an onset stroke or with an onset ischemia, or, you know, MI, and it's important because it doesn't t…”